Eye-Tracking Communication Tool for Non-verbal ICU Patients
Co-design and Pilot Feasibility Evaluation of an Eye-tracking Communication Tool for Conscious Non-verbal ICU Patients: Study Protocol for a Feasibility Randomized Controlled Trial
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
The objectives of this clinical trial are to explore the feasibility of the eye-tracking communication tool in alleviating communication barriers among non-verbal ICU patients. It will also preliminarily investigate the effectiveness of this tool in facilitating communication for these patients. Researchers will compare the eye-tracking communication tool with conventional techniques (such as body language, writing boards, etc.) to observe the feasibility and preliminary effectiveness of the eye-tracking communication tool in alleviating communication barriers. Participants will use an eye-tracking communication tool for augmentative communication for 2 consecutive days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
May 27, 2026
May 1, 2026
2 years
September 2, 2025
May 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Communication difficulty
The degree of communication difficulty in non-verbal ICU patients will be assessed using the Ease of Communication Scale. This tool was revised by Menzel et al.in 1998 and has previously been used to assess communication difficulties among non-verbal patients in the ICU. The scale comprises 6 items, with response options ranging from 0 (no difficulty at all) to 4 (extreme difficulty). The total score ranges from 0 to 24, with higher scores indicating greater communication difficulties.
up to 2days after enrollment
Secondary Outcomes (7)
Well-being and safety
at 4:00 PM daily
Satisfaction of family members
up to 2 days after enrollment
Communication burden of ICU healthcare professionals
up to 2 days after enrollment
Nurses' compliance
through study completion,an average of 2 year
Time spent training patients during initial use
Day 1
- +2 more secondary outcomes
Study Arms (2)
Control Group:conventional techniques group
NO INTERVENTIONCharge nurses will lead communication through conventional methods, including body language (e.g., pointing, nodding, shaking the head) or by providing writing boards for patients to write. Patients unable to write will communicate solely through body language.
Intervention Group
EXPERIMENTALCharge nurses will lead communication using the eye-tracking communication tool.
Interventions
The eye-tracking interactive interface designed based on evidence-based and co-design.The eye-tracking communication tool consists of an eye-tracker, a tablet, and a floor-standing stand. The tool will be placed at the patient's bedside 24 hours a day to facilitate real-time communication.
Eligibility Criteria
You may qualify if:
- aged ≥ 18 years
- ICU stay ≥ 24 hours
- unable to communicate through normal verbal means due to endotracheal intubation/tracheotomy, muscle or nerve injury, acute/chronic spinal cord injury, etc.
- Richmond Agitation-Sedation Scale (RASS) score ranging from -1 to 1
- able to comply with simple instructions for study participation
You may not qualify if:
- blindness or inability to elevate the eyelids that preclude successful participation in eye-tracking interaction tasks
- cognitive impairment limiting meaningful participation
- severe psychological distress
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2025
First Posted
October 3, 2025
Study Start
July 1, 2026
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
May 27, 2026
Record last verified: 2026-05